This podcast episode features perspectives from 2 HIV experts in the Asia-Pacific region on HIV treatment and prevention research findings from the past year, including insights on 2-drug oral regimens, 2-drug long-acting injectable therapy, and long-acting pre-exposure prophylaxis, as well as important considerations related to care for the aging population of people with HIV in the region.
In this episode, 2 HIV experts from the Asia-Pacific region share their thoughts on some of the most important new insights from HIV treatment and prevention research over the past year.
Specifically, the faculty discuss the role of newer innovations in HIV, including 2-drug oral antiretroviral therapy (ART) regimens, 2-drug long-acting injectable ART, and long-acting HIV pre-exposure prophylaxis in HIV care in the Asia-Pacific region, as well as the implications of weight gain with ART and important considerations related to the unique challenges associated with caring for the aging population of people with HIV in the region.
Presenters:
Anchalee Avihingsanon, MD, PhD
HIV-NAT, Thai Red Cross AIDS Research Centre
Pathumwan, Bangkok, Thailand
Senior Clinical Trial
Medicine
Bangkok, Thailand
Reena Rajasuriar, BPharm, MPharm, PhD
Associate Professor
Department of Medicine
University of Malaya
Kuala Lumpur, Malaysia
Content based on an online program supported by an independent educational grant from Gilead Sciences, Inc. andViiV Healthcare.
Link to full program:
bit.ly/3Hz0jNa